Stereotactic Lung Re-Irradiation After a First Course of Stereotactic Radiotherapy with In-Field Relapse: A Valuable...

Area of Science:

• Oncology
• Radiation Oncology
• Pulmonary Medicine

Background:

• Stereotactic body radiation therapy (SBRT) is effective for early-stage lung cancer.
• Local relapse occurs in 5-15% of patients post-SBRT, with limited salvage options.

Purpose of the Study:

• To review modalities and outcomes of repeat SBRT for local recurrence after initial lung SBRT.

Main Methods:

• Exhaustive literature review of 21 studies on repeat lung SBRT.

Main Results:

• Repeat SBRT achieved 1- and 2-year local control rates of 70-90% and 45-80%.
• 1- and 2-year overall survival rates reached up to 95% and 85%.
• Toxicity was rare but could be severe (≈5% Grade 4/5); dose and tumor location influenced outcomes.

Conclusions:

• Repeat lung SBRT is a feasible option for local recurrence.
• Careful patient selection, cumulative dose management, and consideration of tumor location are vital to limit toxicity.
• Further research is needed to optimize SBRT re-irradiation parameters.